1. Home
  2. PDLB vs PRQR Comparison

PDLB vs PRQR Comparison

Compare PDLB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • PRQR
  • Stock Information
  • Founded
  • PDLB 1960
  • PRQR 2012
  • Country
  • PDLB United States
  • PRQR Netherlands
  • Employees
  • PDLB 237
  • PRQR N/A
  • Industry
  • PDLB
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDLB
  • PRQR Health Care
  • Exchange
  • PDLB Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • PDLB 293.5M
  • PRQR 309.5M
  • IPO Year
  • PDLB 2017
  • PRQR 2014
  • Fundamental
  • Price
  • PDLB $13.18
  • PRQR $2.87
  • Analyst Decision
  • PDLB
  • PRQR Strong Buy
  • Analyst Count
  • PDLB 0
  • PRQR 5
  • Target Price
  • PDLB N/A
  • PRQR $7.60
  • AVG Volume (30 Days)
  • PDLB 35.9K
  • PRQR 453.0K
  • Earning Date
  • PDLB 01-28-2025
  • PRQR 11-07-2024
  • Dividend Yield
  • PDLB N/A
  • PRQR N/A
  • EPS Growth
  • PDLB N/A
  • PRQR N/A
  • EPS
  • PDLB 0.37
  • PRQR N/A
  • Revenue
  • PDLB $79,488,000.00
  • PRQR $20,506,357.00
  • Revenue This Year
  • PDLB N/A
  • PRQR $370.31
  • Revenue Next Year
  • PDLB $11.39
  • PRQR N/A
  • P/E Ratio
  • PDLB $36.15
  • PRQR N/A
  • Revenue Growth
  • PDLB 33.32
  • PRQR 306.68
  • 52 Week Low
  • PDLB $7.89
  • PRQR $1.61
  • 52 Week High
  • PDLB $13.43
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 60.41
  • PRQR 38.77
  • Support Level
  • PDLB $13.08
  • PRQR $3.26
  • Resistance Level
  • PDLB $13.43
  • PRQR $3.46
  • Average True Range (ATR)
  • PDLB 0.22
  • PRQR 0.21
  • MACD
  • PDLB -0.03
  • PRQR -0.08
  • Stochastic Oscillator
  • PDLB 62.79
  • PRQR 1.19

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Share on Social Networks: